BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 10406461)

  • 21. Thyrotropin-releasing hormone stimulates phosphorylation of the epidermal growth factor receptor in GH3 pituitary cells.
    Wang YH; Jue SF; Maurer RA
    Mol Endocrinol; 2000 Sep; 14(9):1328-37. PubMed ID: 10976912
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ras-dependent and -independent pathways target the mitogen-activated protein kinase network in macrophages.
    Büscher D; Hipskind RA; Krautwald S; Reimann T; Baccarini M
    Mol Cell Biol; 1995 Jan; 15(1):466-75. PubMed ID: 7799956
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular pathways mediating activation by kainate of mitogen-activated protein kinase in oligodendrocyte progenitors.
    Liu HN; Larocca JN; Almazan G
    Brain Res Mol Brain Res; 1999 Mar; 66(1-2):50-61. PubMed ID: 10095077
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dissociation of dopamine from its receptor as a signal in the pleiotropic hypothalamic regulation of prolactin secretion.
    Martinez de la Escalera G; Weiner RI
    Endocr Rev; 1992 May; 13(2):241-55. PubMed ID: 1618163
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiple intracellular signallings are involved in thyrotropin-releasing hormone (TRH)-induced c-fos and jun B mRNA levels in clonal prolactin cells.
    Passegue E; Richard JL; Boulla G; Gourdji D
    Mol Cell Endocrinol; 1995 Jan; 107(1):29-40. PubMed ID: 7796933
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of protein phosphatase PP1 in GH3B6, but not in GH3 cells, activates the MEK/ERK/c-fos pathway and the human prolactin promoter, involving the coactivator CPB/p300.
    Manfroid I; Martial JA; Muller M
    Mol Endocrinol; 2001 Apr; 15(4):625-37. PubMed ID: 11266513
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Possible involvement of mitogen-activated protein kinase phosphatase-1 (MKP-1) in thyrotropin-releasing hormone (TRH)-induced prolactin gene expression.
    Oride A; Kanasaki H; Purwana IN; Miyazaki K
    Biochem Biophys Res Commun; 2009 May; 382(4):663-7. PubMed ID: 19289102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insulin-like growth factor-1 stimulates rat prolactin gene expression by a Ras, ETS and phosphatidylinositol 3-kinase dependent mechanism.
    Castillo AI; Tolon RM; Aranda A
    Oncogene; 1998 Apr; 16(15):1981-91. PubMed ID: 9591782
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ca2(+)-independent secretory mechanism of thyrotropin-releasing hormone (TRH) involves protein kinase C in rat pituitary cells.
    Yajima Y; Akita Y; Yamaguchi A; Saito T
    Biochem Biophys Res Commun; 1990 Dec; 173(2):571-7. PubMed ID: 2124486
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tpl-2 induces IL-2 expression in T-cell lines by triggering multiple signaling pathways that activate NFAT and NF-kappaB.
    Tsatsanis C; Patriotis C; Tsichlis PN
    Oncogene; 1998 Nov; 17(20):2609-18. PubMed ID: 9840924
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence that signalling pathways by which thyrotropin-releasing hormone and gonadotropin-releasing hormone act are both common and distinct.
    Kaiser UB; Katzenellenbogen RA; Conn PM; Chin WW
    Mol Endocrinol; 1994 Aug; 8(8):1038-48. PubMed ID: 7527898
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential regulation of pituitary hormone secretion and gene expression by thyrotropin-releasing hormone. A role for mitogen-activated protein kinase signaling cascade in rat pituitary GH3 cells.
    Kanasaki H; Yonehara T; Yamamoto H; Takeuchi Y; Fukunaga K; Takahashi K; Miyazaki K; Miyamoto E
    Biol Reprod; 2002 Jul; 67(1):107-13. PubMed ID: 12080005
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preferential role of calcium in the regulation of prolactin gene transcription by thyrotropin-releasing hormone in GH3 pituitary cells.
    Laverriere JN; Tixier-Vidal A; Buisson N; Morin A; Martial JA; Gourdji D
    Endocrinology; 1988 Jan; 122(1):333-40. PubMed ID: 2446857
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thyroliberin and dihydropyridines modulate prolactin gene expression through interacting pathways in GH3 cells.
    Laverrière JN; Richard JL; Buisson N; Martial JA; Tixier-Vidal A; Gourdji D
    Neuroendocrinology; 1989 Dec; 50(6):693-701. PubMed ID: 2482456
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of extracellular signal-regulated kinase (ERK) and induction of mitogen-activated protein kinase phosphatase 1 (MKP-1) by perifused thyrotropin-releasing hormone (TRH) stimulation in rat pituitary GH3 cells.
    Oride A; Kanasaki H; Mutiara S; Purwana IN; Miyazaki K
    Mol Cell Endocrinol; 2008 Dec; 296(1-2):78-86. PubMed ID: 18824214
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epidermal growth factor and Ras regulate gene expression in GH4 pituitary cells by separate, antagonistic signal transduction pathways.
    Pickett CA; Gutierrez-Hartmann A
    Mol Cell Biol; 1995 Dec; 15(12):6777-84. PubMed ID: 8524243
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular mechanisms for the growth factor action of gastrin.
    Todisco A; Takeuchi Y; Urumov A; Yamada J; Stepan VM; Yamada T
    Am J Physiol; 1997 Oct; 273(4):G891-8. PubMed ID: 9357832
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of the PRL promoter by Akt through cAMP response element binding protein.
    Hayakawa J; Ohmichi M; Tasaka K; Kanda Y; Adachi K; Nishio Y; Hisamoto K; Mabuchi S; Hinuma S; Murata Y
    Endocrinology; 2002 Jan; 143(1):13-22. PubMed ID: 11751586
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A G protein beta gamma dimer-mediated pathway contributes to mitogen-activated protein kinase activation by thyrotropin-releasing hormone receptors in transfected COS-7 cells.
    Palomero T; Barros F; del Camino D; Viloria CG; de la Peña P
    Mol Pharmacol; 1998 Apr; 53(4):613-22. PubMed ID: 9547350
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Calcium/calmodulin-dependent protein kinase-II activation in rat pituitary cells in the presence of thyrotropin-releasing hormone and dopamine.
    Cui ZJ; Gorelick FS; Dannies PS
    Endocrinology; 1994 May; 134(5):2245-50. PubMed ID: 8156928
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.